19.02.2013 Views

4th EucheMs chemistry congress

4th EucheMs chemistry congress

4th EucheMs chemistry congress

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Poster Session 1<br />

s902<br />

chem. Listy 106, s587–s1425 (2012)<br />

Poster session 1 - life sciences<br />

P - 0 0 8 4<br />

CoBALt-BindinG CAPACity of the Bovine<br />

SeruM ALBuMin treAted in vitro By vAriouS<br />

oxidizinG AGentS<br />

v. zAitSev 1 , e. LituS 1 , A. zhdAnovA 2 ,<br />

n. KoSterinA 1 , A. ryAKShinA 1<br />

1 Volgograd State Medical University, Basic and Clinical<br />

Bio<strong>chemistry</strong>, Volgograd, Russia<br />

2 Volgograd State Medical University, University Clinic no.1,<br />

Volgograd, Russia<br />

Various properties of the serum albumin are often used as<br />

basis of a number of clinical laboratory tests. One of them is the<br />

ACB test proposed by Bar-Or et al. to detect myocardial ischemia.<br />

Hypothesis which underlies this test is reduction of the serum<br />

albumin cobalt-binding capacity (CoBC) due to oxidative<br />

modification during the blood passes through hypoxic<br />

myocardium. However, genuine ‘ishemia-modified albumin’<br />

(IMA) has not been purified yet. Moreover, controversal data<br />

about clinical significance of the ACB test has risen. We proposed<br />

diagnostic ambiguity of the ACB test might be concerned with<br />

IMA propeties which have not determinated clearly. We examined<br />

whether various oxidizing agents could change CoBC of the<br />

serum albumin diversely. The bovine serum albumin (BSA) was<br />

used as model protein. We measured CoBC by colourimetric<br />

dithiothreitol assay. The tested oxidizing agents were the Fenton’s<br />

reagents and NaOCl. All tested oxidizing agents caused weak<br />

accumulation of dinitrophenylhydrazine-reactive carbonyls and<br />

depletion of the thiol groups in BSA. However, effects of<br />

oxidizing agents on CoBC were different. The copper-based<br />

Fenton’s reagent (H O + CuSO ) significantly reduced CoBC of<br />

2 2 4<br />

treated BSA in comparison with native BSA. Effect of the<br />

iron-based Fenton’s reagent (H O + Mohr’s salt) on CoBC was<br />

2 2<br />

negligible. On the contrary, treatment of BSA by NaOCl increased<br />

CoBC value. Although the effect of NaOCl seems surprising,<br />

the chemical modification of ε-NH -groups of Lys by<br />

2<br />

acetylation, deamination, succinylation, or reaction with<br />

2,4-dinitrobenzenesulphonic acid is known to raise the cobalt<br />

binding by human serum albumin. Similarly NaOCl modifies<br />

ε-NH -group of Lys forming the chloramine groups. We suppose<br />

2<br />

the NaOCl-induced increase of BSA CoBC can be produced by<br />

elimination of positive charges of lysines in the protein molecule.<br />

Hence, we showed oxidants can act as both inhibitors and<br />

stimulants of cobalt-binding activity of serum albumin.<br />

Keywords: Proteins; Oxidation; Redox <strong>chemistry</strong>;<br />

4 th <strong>EucheMs</strong> <strong>chemistry</strong> <strong>congress</strong><br />

P - 0 0 8 5<br />

SyntheSiS And StruCture-ACtivity<br />

reLAtionShiPS of BiS-3-ChLoroPiPeridineS<br />

AS BifunCtionAL dnA ALKyLAtinG AGentS<br />

i. zurAvKA 1 , r. GÖttLiCh 1 , A. PinGoud 2 , w. wende 2 ,<br />

e. PetzinGer 3 , J. Geyer 3 , e. eSSid 3<br />

1 Justus-Liebig-University Giessen, Institute of Organic<br />

Chemistry, Giessen, Germany<br />

2 Justus-Liebig-University Giessen, Institute of Bio<strong>chemistry</strong>,<br />

Giessen, Germany<br />

3 Justus-Liebig-University Giessen, Institute of Pharmacology<br />

and Toxicology Faculty of Veterinary Medicine, Giessen,<br />

Germany<br />

Bifunctional alkylating agents such as chlorambucil and<br />

melphalan represent an important class of clinical cancer<br />

chemotherapeutics. The antitumor antibiotics azinomycin A and<br />

B have the ability to alkylate and cross-link DNA. However, their<br />

poor chemical stability suggests that these natural products are<br />

unlikely to progress as therapeutic candidates. Yet they can act as<br />

lead structures from which to develop potentially useful new<br />

molecules. [1]<br />

Due to our interest in developing more effective bifunctional<br />

alkylating agents, we designed novel bis-3-chloropiperidines<br />

based upon the azinomycins backbone. [2] The nitrogen mustard<br />

moiety is more stable and the alkylating functions generated via<br />

intermediate aziridinium ions are positioned in a similar distance<br />

as has been observed for the azinomycins. [3, 4] To examine the<br />

relationship between structural modifications and DNA alkylating<br />

rates it appeared appealing to introduce aromatic units that might<br />

facilitate DNA interactions. Accordingly, we synthesised a series<br />

of derivatives and evaluated the alkylating properties by<br />

performing a DNA cleavage assay. Furthermore, in vitro cell<br />

cytotoxicity studies of these compounds were carried out using<br />

the MTT method. The biochemical and cytotoxicity results as well<br />

as the synthetic approach to bis-3-chloropiperidines will be<br />

presented.<br />

references:<br />

1. Watanabe, C. M. H. et al. Nat. Prod. Rep., 2011, 28, 693.<br />

2. Roesmann, R., Dissertation 2008,<br />

Justus-Liebig-University Giessen.<br />

3. Shipman, M. et al. Organic Letters, 2004, 6, 3505.<br />

4. Searcey M. et al. Org. Biomol. Chem., 2005, 3, 3585.<br />

Keywords: Antitumor agents; DNA cleavage; Structure-activity<br />

relationships;<br />

AUGUst 26–30, 2012, PrAGUE, cZEcH rEPUbLIc

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!